Cyclerion Therapeutics, Inc. · NASDAQ:CYCN
Tyndall Capital Partners L P's stake in Cyclerion Therapeutics, Inc. fell to 4.80% (Schedule 13G/A)
Event Jun 30, 2025 · Filed Aug 14, 2025
Tyndall Capital Partners L P's stake in Cyclerion Therapeutics, Inc. fell to 4.80%, 155,187 shares, as a passive investor on Jun 30, 2025. Filed Aug 14, 2025 (Schedule 13G/A).
- Stake
- 4.80%
- Shares
- 155,187
- Intent
- Passive
- What changed
- Fell below 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Tyndall Capital Partners, L.P. | 4.80% | 155,187 |
Source
Related
- Cyclerion Therapeutics, Inc.
- Tyndall Capital Partners L P
- Cyclerion Therapeutics, Inc. shareholders
- Schedule 13G/A · Tyndall Capital Partners L P · May 15, 2025
- Form 4 · Chicko Rhonda M. · Aug 18, 2026
- Form 4 · Graul Regina Margaret · Aug 18, 2026
- Schedule 13G · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G · Balyasny Asset Management L.P. · Aug 14, 2026
- Form 4 · Peter M. Hecht · Jul 20, 2026